p<0.05 Joint attention initiations, mean acts/min ±SD: G1+G3a: 0.27 ± 0.21 G2+G3b: 0.07 ± 0.11 p<0.05 Early Social Communication Scales (ESCS), mean joint attention responses ± SD: G1+G3a: 8.11 ± 3.85 C-58 College/professional/ graduate: G1: 5 (36) G2: 3 (30) G3: 1 (11) Household income, mean (range): NR Diagnostic approach: In Study Diagnostic tool/method: CARS Diagnostic category, n (%): Autism G1: 14 (100) G2: 10 (100) G3: 9 (100) Other characteristics , mean ±SD : CARS G1: 35.93 ± 7.49 G2: 39.60 ± 7.74 G3: 38.89 ± 6.95 G2+G3b: 4.93 ± 3.49 p<0.05 ESCS, mean joint attention initiations ± SD: G1+G3a: 6.72 ± 6.29 G2+G3b: 2.47 ± 4.00 p=NS Harms NR Modifiers Chronological age, autism severity as rated by CARS, and mental age by MSEL had no statistically significant effect on treatment response Comments: teachers were the unit of randomization, not the individual children G1: 5 teachers; G2: 4 teachers; G3: 5 teachers; G3a: 2 teachers; G3b: 2 teachers C-59 Table C-1. Evidence table, continued Study Description Intervention Inclusion/ Exclusion Criteria/ Population Baseline Measures Outcomes Author: Adkins et al. 2012 27 Country: US Intervention setting: home Enrollment period: NR Funding: NR Design: RCT Intervention: Sleep education pamphlet for parents Assessments: actigraphy to measure sleep parameters;parents trained in use; and daily diary forms; CSHQ parental questionnaire describing sleep behaviors in children; Stanford Binet 5 or Mullen Scales of Early Learning. Data collected two weeks after randomization Groups: G1: pamphlet G2: no pamphlet Provider: • Parents Treatment manual followed: No Defined protocol followed: NR Measure of treatment fidelity reported: NR Co-interventions held stable during treatment: Yes Inclusion criteria: aged 2-10 years diagnosis ASD based on DSM-IV confirmed by ADOS sleep onset latency of at least 30 minutes on 3 of 7 nights /week based on parent report and confirmed by 14 scorable days of actigraphy showing mean sleep latency of 30 minutes or more medication free or on stable dose of medications (no changes within 30 days of enrollment) parents agreeing to avoid changes in current meds during study time ability of child to tolerate actigraphy and willingness of parents to complete corresponding sleep diary English family primary language Exclusion criteria: medical and behavioral comorbidities that affect sleep, including sleep apnea, epilepsy, gastrointestinal reflux disease, depression, Sleep latency, min mean ± SD: G1: 56.7 ± 27.1 G2: 52.1 ± 25.1 Sleep efficiency, % mean ± SD: G1: 75.5 ± 6.1 G2: 76.8 ± 6.0 Wake after sleep onset, min mean ± SD: G1: 61.9 ± 27.4 G2: 53.2 ± 20.2 Total sleep time, min mean ± SD: G1: 465.7 ± 66.3 G2: 461.4 ± 42.4 Fragmentation, min mean ± SD: G1: 36.8 ± 9.0 G2: 32.2 ± 7.2 Sleep latency, min mean ± SD: G1: 49.5 ± 26.7 G2: 61.3 ± 47.0 p=0.16 Sleep efficiency, % mean ± SD: G1: 77.8 ± 7.0 G2: 75.1 ± 6.7 p=0.04 Wake after sleep onset, min mean ± SD: G1: 60.4 ± 32.1 G2: 59.9 ± 24.2 p=0.22 Total sleep time, min mean ± SD: